Keep posted on news releases via RSS
Surgical sealants, glues, hemostats from fibrin, cyanoacrylates, bioglues drive $14 billion market
Apr 13, 2012
Competing against sutures and staples, advanced wound closure, sealing, hemostasis and anti-adhesion products are steadily gaining revenues. A new February 2012 report from MedMarket Diligence details this global $14 billion market.
Global Surgical Sealants Market Forecast in New Report from MedMarket Diligence, LLC
Mar 05, 2012
Products for hemostasis, sealing, closure and other wound management reflect diverse technologies, as advanced types steadily make inroads in to traditional wound products. MedMarket Diligence has published its 2012 global analysis of this market.
Surgical sealants, glues, hemostats, anti-adhesion and other wound products, market forecast
Jan 25, 2012
Competitors in the market for adjunctive wound securement products are seeking to grow and/or expand their presence and revenue streams in the medical and surgical wound management market. MedMarket Diligence forecasts the market opportunity.
Growth and Opportunity in Global Spine Surgery Device Markets
Aug 18, 2011
Global markets for devices in spine surgery are ripe with innovation and continue to offer up opportunities despite cost pressures, a challenging economic climate and uncertain regulatory trends, according to a new report from MedMarket Diligence.
Global Spine Surgical Technologies Forecast 2011-2020
Jul 26, 2011
Spine surgery, like all medtech markets, is under immense pressure to rein in costs, yet unabated market drivers and innovation by manufacturers make spine surgery a continued strong market opportunity, according to a new MedMarket DIligence report.
Outlook still strong for new drugs and device technologies in obesity
Jun 13, 2011
Too much attention has been given to recent setbacks for drugs in obesity treatment and not enough has been paid to the persistent opportunities for the many pending pending devices and drugs. A 2011 MedMarket Diligence report details the outlook.
Devices and Drugs in Treatment of Obesity Represent a $1.2 Billion Market Growing at Double Digit Rate, According to New Report
January 20, 2011
The global pandemic of obesity, with particular emphasis in Western economies, is driving the development, marketing and sales of diverse treatment options at an aggressive rate. Over the next ten years, the market will see big shifts as new products -- drugs and devices -- are introduced to the market and take hold in clinical practice. The worldwide market for these products, the competitors and the outlook are forecasted in a new report from MedMarket Diligence.